New hives drug put to the test in everyday life
NCT ID NCT07408219
Summary
This study aims to see how well a drug called remibrutinib works for people with chronic hives in real-world settings, outside of a controlled clinical trial. It will enroll 350 adults in the US who are starting this medication. Researchers will track how well the drug controls hives symptoms and how satisfied patients are with their treatment over four weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis
RECRUITINGEast Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.